Recruiting and retaining diverse populations in clinical research is critically important. Over the years, we have seen improvements in the representation of women in clinical trials submitted in FDA marketing applications, and we are encouraged by the potential for new strategies to further their representation.
Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA.